RTC-30 (C007B-415843)

RTC-30 is an optimized phenothiazine with anti-cancer potency. RTC-30 contains a hydroxylated linker (N) that confers increased oral bioavailability.In VitroRTC-30 (0-40 μM; 48 hours) inhibits H1650 lung adenocarcinoma cell growth with an GI 50 of 15 μM. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: H1650 lung adenocarcinoma cells Concentration: 0 μM, 1 μM, 10 μM, 20 μM, 30 μM, 40μM Incubation Time: 48 hours Result: Inhibited H1650 lung adenocarcinoma cell growth.Form:Solid. Specification: 0.99 Molecular Formula: C24H23F3N2O4S Molecular Weight: 492.51 PubChem CID: 71263372 Isomeric SMILES: C1CC2=CC=CC=C2N(C3=CC=CC=C31)C[C@H](CNS(=O)(=O)C4=CC=C(C=C4)OC(F)(F)F)O

UPC:

51111661

Condition:

New

Weight:

1.06 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

R649359-5mg

CAS:

1423077-95-5

Product Size:

5mg